Health Condition 1: F42- Obsessive-compulsive disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients with a diagnosis of OCD as per DSM 5 criteria 2 Age between 18 and 60 years 3 OCD with severity moderate or higher YBOCS MORE THAN 15 4 Patient on a stable dose of SSRI medication Fluoxetine equivalent dose of 40 to 80 mg per day for at least 1 month and a maximum duration of 3 months 5 Participant agreeing to give written informed consent
Exclusion criteria
Exclusion criteria: 1 Other comorbid psychiatric illnesses (except tobacco use disorder and mild to moderate depression) 2 Any medical morbidity that significantly interferes with psychiatric assessmenent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effectiveness of acTBS protocol targeting left supplementary motor area and aiTBS at left dorsolateral prefrontal cortex in reducing the YBOCS score among patients with Obsessive Compulsive DisorderTimepoint: Assessment will be done at baseline, week 1, week 2, and week 4 of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary objective To determine the change in resting motor threshold (RMT) among patients with Obsessive Compulsive Disorder with acTBS protocol targeting left supplementary motor area versus aiTBS at left dorsolateral prefrontal cortex To determine the change in depressive symptoms and subjective well-being among patients with Obsessive Compulsive Disorder with acTBS protocol targeting left supplementary motor area versus aiTBS at left dorsolateral prefrontal cortexTimepoint: baseline, after 10 sessions, after 20 sessions, and 4 weeks after 20 sessions | — |
Countries
India
Contacts
King Georges Medical University